Diagnostic technology provider Eurofins Technologies has reportedly made it to the headlines for launching a unique solution in the wake of the coronavirus epidemic. Reliable sources claim that the company has apparently come forth with an integrated solution called GeneScan VIRSeek SARS-CoV-2 RT-PCR, which includes RNA extraction, and also test kits that are based on real time Reverse transcription polymerase chain reaction.
The launch has been targeted toward detecting the SARS-CoV-2 in environmental surface swabs. Apparently, recent studies claim that it is likely for the SARS-CoV-2 to may remain viable on various surfaces, up to 72 hours.
Sources familiar with the knowledge of the matter state that this VIRSeek suite of test kits as well as workflows will deliver customers with fast tests so that a broad screening for detecting the presence of SARS-CoV-2 becomes viable. The test suite will also provide customers with verification of results by means of an independent test. This in consequence will help enterprises across various industries as well as in transportation, healthcare, and other environments to aid in the testing, detection, monitoring, and strengthening of the sanitation measures enforced, thereby contributing to better health and safety.
Dr. Gilles Martin, Chief Executive Officer at Eurofins Scientific, has been quoted to state that the company is rather pleased to provide other firms and health authorities with options for testing the presence of SARS-CoV-2 in their environments. Eurofins believes that this solution is likely to play a vital role in the effectiveness of sanitation processes and hygiene monitoring, Martin says, adding that the kit will also be used by numerous Eurofins testing laboratories worldwide in order to deliver quick, turnaround testing services and lend support their clients’ requirements wherever necessary.
For the record, Eurofins is one of the leading companies in the esoteric clinical diagnostic testing space and offers a portfolio of more than 200,000 analytical methods in order to evaluate the safety, composition, identity, authenticity, traceability, origin, and purity of biological substances and products.